The impact of SARS-CoV-2 infection during pregnancy on obstetric and neonatal outcomes
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 75D30120C0818600001
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D30120C08186 Federal contract award
- NAICS code
- 611310 Colleges, Universities, and Professional Schools
- PSC
- AJ13 General Science & Technology R&D Svcs; General Science & Technology; Experimental Development
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Limited/Sole Source Justification Notice from the Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services provides a justification for a $1,748,619 modification to contract no. 75D301-20-C-08186 awarded under unusual and compelling urgency to Icahn School of Medicine at Mount Sinai. The original contract supported a prospective pregnancy cohort study assessing SARS-CoV-2 infection, immune response, and pregnancy outcomes over ten months; this modification adds a questionnaire, collection of placenta samples, and enhanced immune analysis to directly inform the agency's understanding of COVID-19 impacts on pregnancy within an expedited timeframe.
Notice text
CDC awarded modification 00001 to contract no. 75D301-20-C-08186 to the Icahn School of Medicine at Mount Sinai, One Gustave L Levy Pl, New York, NY 10029-6504, on May 19, 2021 in the amount of $1,748,619.
This notices makes available a justification and approval for other than full and open competition (JOFOC) that applies to this contract modification.
This contract modification was awarded under the authority of FAR 6.302-2, Unusual and compelling urgency.
The original contract was for a prospective pregnancy cohort study thorough assessments of SARS-CoV-2 infection and immune response in pregnant women (symptomatic and asymptomatic), and in-depth assessment of pregnancy, fetal, and neonatal outcomes. The original contract included the analysis of blood samples and extraction of data from electronic medical records. The work added by this modification adds a questionnaire for a subset of the study sample, collection of placenta samples, and an in-depth immune response analysis.
This requirement is a time-sensitive need of the agency as the findings from this study will directly inform the understanding of the impact of COVID-19 on pregnancy, fetal, and neonatal outcomes. Delaying this modification would have detrimental effects on the agency's response effort to COVID-19 by delaying the collection and analysis of this data. Mt. Sinai, the incumbent contractor, has performed a prospective pregnancy cohort study for the past ten months. Mt. Sinai has assembled a large sample for this cohort study which makes it uniquely suited to perform these follow-on study tasks.
The attached JOFOC is being made available within 30 days of the contract modification award in accordance with FAR 6.305 and will remain active for 30 days.
Awarded contract 75D30120C08186 to unknown vendor for unknown amount on 2021-05-19.
Files
| File | Type | Posted |
|---|---|---|
| HHS COVID-19 Class JA.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity